Reference men with b2/b4 duplication compared to subjects with no AZFc rearrangements showed a trend for lower follicle-stimulating hormone (FSH) (median 2.3 [5–95% range 1.4–7.5] vs 3.2 [1.3–7.1] IU/l; p<0.05) and luteinizing hormone (LH) (3.1 [1.7–5.0] vs 3.8 (1.7–7.2) IU/l; p<0.05).
Listeria monocytogenes strains of serotypes 3a (at 6.597 ± 0.418 h), 3b (5.717 ± 0.086 h), 4b (5.739 ± 0.111 h) and 4d (5.729 ± 0.133 h) showed a trend to have the longest values for L ( p < 0.05).
In Met, LoDG and MetDG compared to CTRL, hexose showed a trend towards lower levels ( p > 0.05, Fig. 5 ).
Analyses of CD8 + T cells showed a trend towards increased single IFN-γ and dual cytokine expression in the BoHV-4-M-NSP5 prime-boost group over time ( P > 0.05; Figures 3D, E ).
When ADHD traits at 2 years were included in the model the overall regression was statistically significant ( r 2 = 0.640, F (2,79) = 68.44, p < 0.001), ADHD traits at age 2 significantly predicted ADHD traits at age 3 (β = 0.798, p < 0.001), and Prohibition scores at age 2 showed a trend-level predictive association to ADHD traits at age 3 (β = 0.035, p = 0.050).No other predictive associations from EF performance at 2 years to 3-year autism and ADHD traits were found.
Meanwhile, higher serum CA-125 levels (≥90 IU/mL) at the first recurrence showed a trend toward worse OS with borderline statistical significance ( P = 0.050) (Table 2 ).
Outcomes showed a trend toward better outcomes with TLT, but ultimately these failed to reach statistical significance ( P < 0.05).
Although ChatMyopia showed a trend toward reducing decisional conflict, the difference was not statistically significant ( p > 0.05) ( Figure 4 C).
However, anti-EA IgM ( Figure 5D ), and anti-EBNA6 IgM ( Figure 5E ) showed a trend to react differently in ME/CFS samples versus BD control samples ( p > 0.05, Fisher exact test) but did not reach statistical significance.
Asthmatics showed a trend toward a lower percentage of predicted FVC ( p = 0.05) and FEV 1 ( p = 0.08), but FENO was similar among asthmatics and controls.
Complex network analysis further indicated that during resting state, the taVNS group showed a trend of increased nodal clustering coefficient in the ipsilesional DLPFC compared to the Sham group ( P < 0.05).
In fact, freezing in the trained context showed a trend toward a decline in aged mice from 1 to 30 d ( F (1,83) = 3.9, P = 0.05), reflective of an age-dependent impairment in “systems” memory consolidation (compare light gray bars in Fig. 2 A).
The other regions showed a trend towards indicator stability (p > 0.05).
Although the DASHI showed a trend toward an inverse association in the upper quartiles, these findings were not statistically significant ( P > 0.05).
Non-hematological disorders showed a trend toward a better OS (77.9 vs. 62.9%; p = 0.05).
For DHM and its derivatives, the peroxide values showed a trend of C4-DHM < DHM < C2-DHM < C8-DHM < C6-DHM < C12-DHM ( p < 0.05), and the TBARS values showed a trend of DHM ≈ C4-DHM < C2-DHM < C8-DHM < C6-DHM < C12-DHM ( p < 0.05).
However, in the total patient group and the Phaco-GATT group, MD at 6 and 12 months showed a trend toward progression compared to baseline ( P < 0.05).
Patients in each group showed a trend of gradual improvement after surgery ( P < 0.05).
Compared with the FMT‐spost group, transplanting feces from pre‐inoculation group also showed a trend of shrinking tumor volume, though not reaching the statistic threshold ( P > 0.05).
The rs1956529 polymorphism showed a trend toward a positive association ( p < 0.05) with the DHC in the meta-analysis.
In addition, per-protocol analyses showed a trend towards a lower %NKG2D CD56 bright NK cells (β = −3.1%, 95%CI = −6.3; 0.1, p = 0.05) and %CD62L CD56 dim NK cells (β = −5.1%, 95%CI = −11.3; 1.1, p = 0.10) in the exercise group compared to the control group after chemotherapy.
All of them showed a trend of 0–10 cm > 10–20 cm > 20–30 cm > 30–40 cm ( P < 0.05), and the total bacterial abundance increased significantly in all sediment layers.
Effects of RP-GABA on growth-related measures under different THI conditions As shown in Supplementary Figure S2 , compared with the control group, RP-GABA supplementation showed a trend toward increased body weight under THI 45, THI 63, and THI 28; however, the differences between groups within each THI condition were not significant ( p > 0.05).
The beneficial effect of canagliflozin on 3P-MACE was confirmed in patients with T2D and CKD in a subsequent renal outcomes trial, CREDENCE (HR [95% CI] 0.80 [0.67–0.95], p = 0.01), which also showed a trend towards a reduction in CV deaths that neared significance (HR [95% CI] 0.78 [0.61–1.00], p = 0.05) [ 36 ].
764.0, P = 0.011) and showed a trend towards more FIGO stage IV disease (63.3% vs. 40.4%, P = 0.050), compared to those with PDS.